These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7371235)

  • 1. Tumour histology and spleen size in women with breast cancer.
    Roberts JG; Chare MJ; Fortt RW; Leach KG; Baum M
    Clin Oncol; 1980 Mar; 6(1):33-8. PubMed ID: 7371235
    [No Abstract]   [Full Text] [Related]  

  • 2. Spleen size in women with breast cancer.
    Roberts JG; Chare MJ; Leach KG; Baum M
    Clin Oncol; 1979 Dec; 5(4):317-23. PubMed ID: 519916
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: The relationship between spleen size, clinical staging and histological features in breast cancer.
    Roberts JG; Mander AM; Fortt RW; Leach KG; Bligh AS; Baum M
    Br J Surg; 1975 Feb; 62(2):159-60. PubMed ID: 1115904
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour size as a predictor of axillary node metastases in patients with breast cancer.
    Laura S; Coombs NJ; Ung O; Boyages J
    ANZ J Surg; 2006 Nov; 76(11):1002-6. PubMed ID: 17054550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histological predictors of contralateral breast cancer.
    Kollias J; Ellis IO; Elston CW; Blamey RW
    Eur J Surg Oncol; 1999 Dec; 25(6):584-9. PubMed ID: 10556004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen white pulp morphology related to immunological reactivity of women died of widespread breast carcinoma.
    Syrjänen KJ
    Neoplasma; 1980; 27(3):307-15. PubMed ID: 7453851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcium and tumour aggressiveness in breast cancer: a prospective study of 7847 women.
    Almquist M; Anagnostaki L; Bondeson L; Bondeson AG; Borgquist S; Landberg G; Malina J; Malm J; Manjer J
    Eur J Cancer Prev; 2009 Sep; 18(5):354-60. PubMed ID: 19593149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of size of primary breast tumour on local control.
    Olasinde TA; Handl-Zeller L
    Afr J Med Med Sci; 1993 Sep; 22(3):65-8. PubMed ID: 7839915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of synchronous bilateral breast cancer.
    Irvine T; Allen DS; Gillett C; Hamed H; Fentiman IS
    Br J Surg; 2009 Apr; 96(4):376-80. PubMed ID: 19283743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors affecting the natural history of node-negative breast cancer.
    Trudeau ME; Pritchard KI; Chapman JA; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; Andrulis I; McCready DR; Lickley HL
    Breast Cancer Res Treat; 2005 Jan; 89(1):35-45. PubMed ID: 15666195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer in women aged 35 and under: prognosis and survival.
    Jmor S; Al-Sayer H; Heys SD; Payne S; Miller I; Ah-See A; Hutcheon A; Eremin O
    J R Coll Surg Edinb; 2002 Oct; 47(5):693-9. PubMed ID: 12463710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients].
    Ben Ahmed S; Aloulou S; Bibi M; Landolsi A; Nouira M; Ben Fatma L; Kallel L; Gharbi O; Korbi S; Khaïri H; Kraïem C
    Sante Publique; 2002 Sep; 14(3):231-41. PubMed ID: 12564048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node status.
    Dent R; Hanna WM; Trudeau M; Rawlinson E; Sun P; Narod SA
    Cancer; 2009 Nov; 115(21):4917-23. PubMed ID: 19691094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancer.
    Jayasinghe UW; Boyages J
    Breast; 2009 Feb; 18(1):41-6. PubMed ID: 19028098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.